Accelerate Diagnostics Inc EV/EBIT
Quel est le EV/EBIT de Accelerate Diagnostics Inc?
Le EV/EBIT de Accelerate Diagnostics Inc est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur NASDAQ par rapport à Accelerate Diagnostics Inc
Que fait Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Entreprises avec ev/ebit similaire à Accelerate Diagnostics Inc
- Centogene NV a EV/EBIT de N/A
- Delek US Inc a EV/EBIT de N/A
- Freeport Resources a EV/EBIT de N/A
- AMMO a EV/EBIT de N/A
- AMMO a EV/EBIT de N/A
- Ultragenyx Pharmaceutical a EV/EBIT de N/A
- Accelerate Diagnostics Inc a EV/EBIT de N/A
- Eros International Plc a EV/EBIT de N/A
- Deveron UAS a EV/EBIT de N/A
- HT Media a EV/EBIT de N/A
- Aguila American Gold a EV/EBIT de N/A
- Sri Adhikari Brothers Television Network a EV/EBIT de N/A
- Zicom Electronic Security Systems a EV/EBIT de N/A